They then found that DFG-out Raf inhibitors could inhibit Raf-1, leading to SCD1 degradation that aroused the overload of toxic saturated fatty acids, consequently resulting in the apoptosis of HCC cells. The gene discussed is SCD; the disease is hepatocellular carcinoma.